(4-BENZYL-TETRAHYDRO-2,2-DIMETHYL-2H-PYRAN-4-YL)ACETIC ACID
|
- $378 - $874
- Product name: (4-BENZYL-TETRAHYDRO-2,2-DIMETHYL-2H-PYRAN-4-YL)ACETIC ACID
- CAS: 109878-51-5
- MF: C16H22O3
- MW: 262.34
- EINECS:
- MDL Number:MFCD01596815
- Synonyms:(4-BENZYL-TETRAHYDRO-2,2-DIMETHYL-2H-PYRAN-4-YL)ACETIC ACID;(4-Benzyl-2,2-dimethyl-tetrahydro-pyran-4-yl)-acetic acid;2-(4-Benzyl-2,2-dimethyltetrahydro-2H-pyran-4-yl)acetic acid;Reaxys ID: 4315847;2H-Pyran-4-acetic acid, tetrahydro-2,2-dimethyl-4-(phenylmethyl)-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0081090
- Product description(4-BENZYL-2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID 95.00%
- Packaging500MG
- Price$796.95
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11352758
- Product description2-(4-Benzyl-2,2-dimethyltetrahydro-2H-pyran-4-yl)aceticacid 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number032720
- Product description(4-Benzyl-2,2-dimethyl-tetrahydro-pyran-4-yl)-acetic acid
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0081090 | (4-BENZYL-2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID 95.00% | 500MG | $796.95 | 2021-12-16 | Buy |
| Crysdot | CD11352758 | 2-(4-Benzyl-2,2-dimethyltetrahydro-2H-pyran-4-yl)aceticacid 97% | 5g | $874 | 2021-12-16 | Buy |
| Matrix Scientific | 032720 | (4-Benzyl-2,2-dimethyl-tetrahydro-pyran-4-yl)-acetic acid | 1g | $378 | 2021-12-16 | Buy |
Properties
form :solid
Safety Information
| Symbol(GHS): |
|
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||
| Precautionary statements: |
|




